Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Current Medical Research and Opinion|July 26, 2011
A look into the future: improving diabetes care by 2015Stephen Brunton, Stephen Gough, Debbie Hicks, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 30, 2020
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 DiabetesDavid C Wheeler, June James, Dipesh Patel, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2019
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2019
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.Journal of Diabetes|October 7, 2010
Results and analysis of the 2008-2009 Insulin Injection Technique Questionnaire surveyCarina De Coninck, Anders Frid, Ruth Gaspar, et al.American Journal of Infection Control|June 14, 2011
A comparative study to evaluate surface microbial contamination associated with copper-containing and stainless steel pens used by nurses in the critical care unitAnna L Casey, Tarja J Karpanen, Debra Adams, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2022
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical PracticeMarc Evans, Angharad R Morgan, Stephen C Bain, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2020
Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related ComplicationsMarc Evans, Angharad R Morgan, Dipesh Patel, et al.The Lancet. Oncology|November 6, 2018
Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trialTobias Goschzik, Edward C Schwalbe, Debbie Hicks, et al.Neuro-Oncology Advances|July 1, 2024
In vivo modeling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastomaJemma Castle, Gary Shaw, Dominic Weller, et al.Pageof 8